Predictive Oncology | S-3: Registration statement for specified transactions by certain issuers
Predictive Oncology | 8-K: Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
Predictive Oncology | 8-K: Current report
Predictive Oncology | 8-K: Current report
Predictive Oncology | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Predictive Oncology | 8-K: Current report
Predictive Oncology | S-3: Registration statement for specified transactions by certain issuers
Predictive Oncology | 8-K: Current report
Predictive Oncology | 8-K: Current report
Predictive Oncology | 8-K: Current report
Predictive Oncology | 8-K/A: Current report (Amendment)
Predictive Oncology | 8-K: Current report
Predictive Oncology | 8-K: Current report
Predictive Oncology | DEF 14A: Definitive information statements
Predictive Oncology | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Predictive Oncology | 8-K: Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
Predictive Oncology | 8-K: Current report
Predictive Oncology | 8-K: Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
Predictive Oncology | 8-K: Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update
Predictive Oncology | 8-K: Current report
No Data